The US Marshals Service Special Operations Group Camp Beauregard issued a purchase order to Zoll Medical Corporation on August 26, 2022, for patient monitoring equipment with a ceiling value of $33,548.01. The order, valued as a firm fixed price acquisition, carried no small business set-aside. Work is performed at Zoll's facility in Chelmsford, Massachusetts, with an ultimate completion date of March 25, 2023. The purchase order procures Zoll patient monitoring systems for federal emergency...
The US Marshals Service Special Operations Group Camp Beauregard issued a purchase order to Altitude Technologies Inc. (doing business as Chinook Medical Gear) on August 15, 2026, for surgical medical gear totaling $44,165.32 under a Total Small Business set-aside. The awardee is an SBA-certified HUBZone firm and veteran-owned small business. Work is performed in Tulsa, Oklahoma, with an ultimate completion date of August 14, 2027. The order carries firm fixed price terms and supports the...
<p>The Defense Logistics Agency's Medical Supply Chain issued a $274,613.60 delivery order to Zoll Medical Corporation on March 27, 2026, for portable vital signs monitors, with an ultimate completion date of September 14, 2026.</p>
<p>Place of performance is Chelmsford, MA. The order uses fixed-price pricing with economic price adjustment. No set-aside was applied.</p>
<p>The Defense Logistics Agency's Medical Supply Chain division issued a purchase order to Zoll Medical Corporation on March 2, 2026 for a defibrillator-monitor case, valued at $1,867.50 under a firm fixed-price arrangement. The order is due for completion by May 1, 2026. Place of performance is Chelmsford, Massachusetts, where Zoll manufactures the equipment. No set-aside applied to this procurement.</p>
<p>The Defense Logistics Agency's Medical Supply Chain issued a $274,613.60 delivery order to Zoll Medical Corporation on March 26, 2026, for portable vital signs monitors, with a ceiling value of $274,613.60 and an ultimate completion date of September 14, 2026.</p>
<p>Place of performance is Chelmsford, MA. The order is priced as fixed price with economic price adjustment and carries no set-aside designation.</p>
<p>The Defense Logistics Agency Medical Supply Chain issued a $37,707.67 delivery order to Zoll Medical Corporation on March 23, 2026, for an advanced monitor/defibrillator with 12-lead interpretation capability. Work is performed in Chelmsford, MA, with an ultimate completion date of July 30, 2026. The order is priced as fixed price with economic price adjustment and was issued without set-aside.</p>
<p>The Defense Logistics Agency's Medical Supply Chain issued a $274,613.60 delivery order to Zoll Medical Corporation on March 27, 2026, for portable patient vital signs monitors, with an ultimate completion date of September 14, 2026.</p>
<p>Place of performance is Chelmsford, MA. The order is fixed price with economic price adjustment. No set-aside was used.</p>
<p>The Department of Defense Medical Supply Chain issued a $54,555.10 delivery order to Zoll Medical Corporation on April 29, 2026, for a PROPAQ monitor/defibrillator, with completion by December 4, 2026.</p>
<p>Place of performance is Chelmsford, MA. Pricing is fixed price with economic price adjustment. No set-aside was used. The order carries a ceiling value of $54,555.10.</p>
<p>The Defense Logistics Agency's Medical Supply Chain awarded a purchase order to Zoll Medical Corporation on November 18, 2025, for a defibrillator-monitor case valued at $8,590.50 under a firm fixed-price arrangement. Place of performance is Chelmsford, Massachusetts. The order was completed by January 20, 2026. No set-aside was applied.</p>
<p>The Defense Logistics Agency's Medical Supply Chain issued a $274,613.60 delivery order to Zoll Medical Corporation on March 27, 2026, for portable patient vital signs monitoring equipment, with performance completion by September 14, 2026.</p>
<p>Place of performance is Chelmsford, MA. The order carries fixed-price pricing with economic price adjustment. No set-aside was used; the award was issued under unrestricted competition.</p>